CN104587393A - Traditional Chinese medicine composition for treating knee-joint hyperostosis - Google Patents
Traditional Chinese medicine composition for treating knee-joint hyperostosis Download PDFInfo
- Publication number
- CN104587393A CN104587393A CN201510016393.XA CN201510016393A CN104587393A CN 104587393 A CN104587393 A CN 104587393A CN 201510016393 A CN201510016393 A CN 201510016393A CN 104587393 A CN104587393 A CN 104587393A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- chinese medicine
- medicine composition
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicine composition for treating knee-joint hyperostosis. The chronic traditional Chinese medicine composition comprises the following traditional Chinese medicine raw materials in parts by weight: 10 to 30 parts of woodwardia japonica, 5-25 parts of eucommia ulmoides, 5-20 parts of white paeony root, 10-30 parts of fructus psoraleae, 5-20 parts of angelica, 10-40 parts of cornu cervi degelatinatum, 5-20 parts of curculigo orchioides, 10-30 parts of spina gleditsiae, 10-30 parts of cornus officinalis, 5-20 parts of coptis chinensis, 10-30 parts of mulberry, 10-30 parts of grossy privet fruit, 10-30 parts of semen cuscutae, 5-25 parts of barbed skullcap herb, 10-30 parts of edible tulip, 5-20 parts of dried orange peel, 10-40 parts of oldenlandia diffusa, 5-20 parts of epimedium, 5-25 parts of rhizoma sparganii, 5-25 parts of zedoary, 5-20 parts of pinellia ternate and 5-15 parts of radix glycyrrhizae. The traditional Chinese medicine composition has the efficacies of nourishing liver and kidney, strengthening muscles and bones, relieving swelling and pain, promoting blood circulation to remove blood stasis, clearing away heat and drying dampness, and plays a significant and reliable effect on treatment of knee-joint hyperostosis.
Description
Technical field
The present invention relates to a kind of pharmaceutical product not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of knee joint hyperosteogeny.
Background technology
Knee joint hyperosteogeny is also referred to as Hypertrophic degenerative osteoarthritis.It is not joint general inflammation, but a kind of cartilage long-term degradation sexually transmitted disease (STD) becomes.With age,
knee jointall bones are owing to wearing and tearing all the year round, and surrounding ligaments relaxes, and causes joint instability, causes pathological changes to cause corresponding site hyperosteogeny.This kind of hypertrophy is the phenomenon of human senility.After more than 40 year old, most people has hyperosteogeny, and just happening part is different with hyperplasia degree.Its performance is that side or bilateral joint are uncomfortable, pain and swelling.Originally pain is many when long-time walking or stair activity, but has a rest or take a turn for the better after bed.Along with PD, walk level road also pain, movable inconvenient, joint instability, slightly not noting on foot will pain; The sound sent when simultaneously having picture to twist with the fingers hair during knee articulation.Severe one
knee jointalso can suddenly " lock " on a certain position, and separate " lock " time, with obvious snap.At present, the medicine for the treatment of knee joint hyperosteogeny is a lot, though there is certain curative effect, there is the deficiency of easily recurrence and side effect.
Motherland's medical science thinks that knee joint hyperosteogeny is how relevant with wound, strain, obstruction of collaterals by blood stasis, the damp that is affected by the cold, phlegm resistance, caused by liver and kidney deficiency etc.
According to theory of Chinese medical science, for the pathogeny of knee joint hyperosteogeny, adopt the method for the treatment of of nourishing the liver and kidney, bone and muscle strengthening, reducing swelling and alleviating pain, blood circulation promoting and blood stasis dispelling, heat clearing and damp drying, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
Treat to overcome in prior art the deficiency that knee joint hyperosteogeny exists easily recurrence and side effect, the invention provides a kind of prepare easy, cost is low, evident in efficacy, the Chinese medicine composition for the treatment of knee joint hyperosteogeny that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of knee joint hyperosteogeny, it is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Cibotii 10-30 part, Cortex Eucommiae 5-25 part, Radix Paeoniae Alba 5-20 part, Fructus Psoraleae 10-30 part, Radix Angelicae Sinensis 5-20 part, Cornu Cervi Degelatinatum 10-40 part, Rhizoma Curculiginis 5-20 part, Spina Gleditsiae 10-30 part, Fructus Corni 10-30 part, Rhizoma Coptidis 5-20 part, Fructus Mori 10-30 part, Fructus Ligustri Lucidi 10-30 part, Semen Cuscutae 10-30 part, Herba Scutellariae Barbatae 5-25 part, Pseudobulbus cremastrae seu pleiones 10-30 part, Pericarpium Citri Reticulatae 5-20 part, Herba Hedyotidis Diffusae 10-40 part, Herba Epimedii 5-20 part, Rhizoma Sparganii 5-25 part, Rhizoma Curcumae 5-25 part, Rhizoma Pinelliae 5-20 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of knee joint hyperosteogeny, is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Cibotii 20 parts, the Cortex Eucommiae 15 parts, the Radix Paeoniae Alba 10 parts, Fructus Psoraleae 20 parts, Radix Angelicae Sinensis 10 parts, Cornu Cervi Degelatinatum 30 parts, Rhizoma Curculiginis 10 parts, Spina Gleditsiae 20 parts, Fructus Corni 20 parts, Rhizoma Coptidis 10 parts, 20 parts, Fructus Mori, Fructus Ligustri Lucidi 20 parts, Semen Cuscutae 20 parts, Herba Scutellariae Barbatae 15 parts, Pseudobulbus cremastrae seu pleiones 20 parts, Pericarpium Citri Reticulatae 10 parts, Herba Hedyotidis Diffusae 30 parts, Herba Epimedii 10 parts, Rhizoma Sparganii 15 parts, Rhizoma Curcumae 15 parts, the Rhizoma Pinelliae 10 parts, 10 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: Rhizoma Cibotii has the effect in invigorating the liver and kidney, strong spinal column, wind-damp dispelling, sharp joint; The Cortex Eucommiae has effect of invigorating the liver and kidney, bone and muscle strengthening, invigorating middle warmer benefit vital essence; The Radix Paeoniae Alba has effect of clear and coherent blood vessels, nourishing blood to suppress the hyperactive liver, slow middle arresting sweating; Fructus Psoraleae has effect of reinforcing the kidney and supporting YANG, controlling nocturnal emission with astringent drugs reducing urination, warm spleen antidiarrheal, helping inspiration to relieve asthma; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation; Cornu Cervi Degelatinatum has warming the kidney to activate YANG
,anastaltic effect; Rhizoma Curculiginis has effect of reinforcing the kidney and supporting YANG, benefiting essence-blood, bone and muscle strengthening, promoting the circulation of blood detumescence; Spina Gleditsiae has effect of detumescence poison holding, evacuation of pus parasite killing; Fructus Corni has effect of liver and kidney tonifying, essence astringing and desertion stemming; Rhizoma Coptidis has effect of heat clearing and damp drying, eliminating fire and detoxication; Fructus Mori has YIN nourishing of enriching blood, effect of moisturizing of promoting the production of body fluid; Effect that Fructus Ligustri Lucidi has nourishing the liver and kidney, tonifying YIN nourishes blood; Semen Cuscutae has effect of the kidney invigorating and essence nourishing, nourishing the liver spleen invigorating; Herba Scutellariae Barbatae has effect of heat-clearing and toxic substances removing, dissipating blood stasis hemostasis, subduing swelling and relieving pain; Pseudobulbus cremastrae seu pleiones has dispersing swelling and dissipating binds, effect of removing toxic substances of reducing phlegm; Pericarpium Citri Reticulatae has effect of diuretic, drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, tune; Herba Hedyotidis Diffusae has effect of heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain; Herba Epimedii has effect of kidney-replenishing, bone and muscle strengthening, wind-damp dispelling; Rhizoma Sparganii has that the stasis of blood is stimulated the menstrual flow, effect of removing blood stasis eliminating mass, circulation of qi promoting removing food stagnancy; Rhizoma Curcumae has effect of circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving; The Rhizoma Pinelliae has drying dampness to eliminate phlegm, effect of stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass; Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component, through dialectical compatibility, helps using mutually assistant, plays effect of nourishing the liver and kidney, bone and muscle strengthening, reducing swelling and alleviating pain, blood circulation promoting and blood stasis dispelling, heat clearing and damp drying altogether, reach treating both the principal and secondary aspects of a disease to the treatment of knee joint hyperosteogeny.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopts the use that is decocted in water for oral dose.Through clinical practice checking, it is reliably evident in efficacy, mild in medicine property and, do not occur toxic and side effects, effective percentage reaches 94%, cure rate 70%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for knee joint hyperosteogeny, its raw material of Chinese medicine and weight proportion are: Rhizoma Cibotii 20g, Cortex Eucommiae 15g, Radix Paeoniae Alba 10g, Fructus Psoraleae 20g, Radix Angelicae Sinensis 10g, Cornu Cervi Degelatinatum 30g, Rhizoma Curculiginis 10g, Spina Gleditsiae 20g, Fructus Corni 20g, Rhizoma Coptidis 10g, Fructus Mori 20g, Fructus Ligustri Lucidi 20g, Semen Cuscutae 20g, Herba Scutellariae Barbatae 15g, Pseudobulbus cremastrae seu pleiones 20g, Pericarpium Citri Reticulatae 10g, Herba Hedyotidis Diffusae 30g, Herba Epimedii 10g, Rhizoma Sparganii 15g, Rhizoma Curcumae 15g, Rhizoma Pinelliae 10g, Radix Glycyrrhizae 10g.
Embodiment 2
Treat a Chinese medicine composition for knee joint hyperosteogeny, its raw material of Chinese medicine and weight proportion are: Rhizoma Cibotii 15g, Cortex Eucommiae 25g, Radix Paeoniae Alba 5g, Fructus Psoraleae 30g, Radix Angelicae Sinensis 12g, Cornu Cervi Degelatinatum 40g, Rhizoma Curculiginis 5g, Spina Gleditsiae 25g, Fructus Corni 10g, Rhizoma Coptidis 20g, Fructus Mori 15g, Fructus Ligustri Lucidi 30g, Semen Cuscutae 10g, Herba Scutellariae Barbatae 25g, Pseudobulbus cremastrae seu pleiones 15g, Pericarpium Citri Reticulatae 5g, Herba Hedyotidis Diffusae 40g, Herba Epimedii 12g, Rhizoma Sparganii 25g, Rhizoma Curcumae 5g, Rhizoma Pinelliae 20g, Radix Glycyrrhizae 12g.
Embodiment 3
Treat a Chinese medicine composition for knee joint hyperosteogeny, its raw material of Chinese medicine and weight proportion are: Rhizoma Cibotii 25g, Cortex Eucommiae 5g, Radix Paeoniae Alba 15g, Fructus Psoraleae 25g, Radix Angelicae Sinensis 15g, Cornu Cervi Degelatinatum 10g, Rhizoma Curculiginis 20g, Spina Gleditsiae 15g, Fructus Corni 25g, Rhizoma Coptidis 5g, Fructus Mori 30g, Fructus Ligustri Lucidi 10g, Semen Cuscutae 25g, Herba Scutellariae Barbatae 20g, Pseudobulbus cremastrae seu pleiones 10g, Pericarpium Citri Reticulatae 20g, Herba Hedyotidis Diffusae 10g, Herba Epimedii 20g, Rhizoma Sparganii 10g, Rhizoma Curcumae 25g, Rhizoma Pinelliae 15g, Radix Glycyrrhizae 5g.
Embodiment 4
Treat a Chinese medicine composition for knee joint hyperosteogeny, its raw material of Chinese medicine and weight proportion are: Rhizoma Cibotii 10g, Cortex Eucommiae 20g, Radix Paeoniae Alba 12g, Fructus Psoraleae 10g, Radix Angelicae Sinensis 20g, Cornu Cervi Degelatinatum 25g, Rhizoma Curculiginis 12g, Spina Gleditsiae 30g, Fructus Corni 10g, Rhizoma Coptidis 15g, Fructus Mori 10g, Fructus Ligustri Lucidi 25g, Semen Cuscutae 10g, Herba Scutellariae Barbatae 5g, Pseudobulbus cremastrae seu pleiones 25g, Pericarpium Citri Reticulatae 12g, Herba Hedyotidis Diffusae 20g, Herba Epimedii 15g, Rhizoma Sparganii 5g, Rhizoma Curcumae 20g, Rhizoma Pinelliae 12g, Radix Glycyrrhizae 6g.
Embodiment 5
Treat a Chinese medicine composition for knee joint hyperosteogeny, its raw material of Chinese medicine and weight proportion are: Rhizoma Cibotii 40g, Cortex Eucommiae 10g, Radix Paeoniae Alba 20g, Fructus Psoraleae 15g, Radix Angelicae Sinensis 5g, Cornu Cervi Degelatinatum 35g, Rhizoma Curculiginis 15g, Spina Gleditsiae 10g, Fructus Corni 30g, Rhizoma Coptidis 12g, Fructus Mori 25g, Fructus Ligustri Lucidi 15g, Semen Cuscutae 30g, Herba Scutellariae Barbatae 10g, Pseudobulbus cremastrae seu pleiones 30g, Pericarpium Citri Reticulatae 15g, Herba Hedyotidis Diffusae 35g, Herba Epimedii 5g, Rhizoma Sparganii 20g, Rhizoma Curcumae 10g, Rhizoma Pinelliae 5g, Radix Glycyrrhizae 15g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and covers powder, soaks 15 ~ 20 minutes, then adds water and do not have powder about 6 centimetres, carries out first time to decoct, and adopts intense fire to decoct, with slow fire boiling 20 ~ 30 minutes after boiling at a simmer; Second time decocts, and adds water and does not have powder about 4 centimetres, decocts 15 ~ 20 minutes after water boils.Decoct extracting juice twice, merge.
The present invention, with a kind of Chinese medicine composition for the treatment of knee joint hyperosteogeny given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 50 example, man 29 example, female 21 example, 40 ~ 75 years old age.
Two, clinical manifestation:
1. first 1 month most of time has gonalgia;
2. bone sound is had during joint motion;
3. morning, deadlock was less than 30 minutes;
4. the age is more than or equal to 38 years old;
5. knee joint inspection has bone loose.
When meeting 1+2+3+4 bar, or 1+2+5 bar or 1+4+5 person, now diagnosable is knee joint hyperosteogeny.
Three, usage and dosage: during clinical practice, potion on the one, decocting twice extracting juice is about 400ml, point morning, late twice empty stomach decoction being taken warmly.It within six days, is a course for the treatment of.Treatments period is avoided cold and uncooked food the thing of pungent stimulation.
Four, criterion of therapeutical effect:
(1) cure: the transference cures such as the gonalgia, energy normal activity, more than half a year without recurrence;
(2) effective: the symptoms such as the gonalgia obviously alleviate, but meet aggravating activities exacerbation of symptoms;
(3) effective: light when the symptoms such as the gonalgia are heavy, therapeutic effect is not obvious;
(4) invalid: the symptoms such as the gonalgia are without improvement.
Five, therapeutic effect: in this clinical observation case, takes medicine 2-5 the course for the treatment of, and recovery from illness 35 example, follows up a case by regular visits to and have no recurrence; Effective 8 examples, effective 4 examples, invalid 3 examples.There is not toxic and side effects in treatments period.
Six, model case:
Case 1:
In certain, female, 43 years old.Suffer from knee joint hyperosteogeny more than 3 years.Once took multiple western medicines in treatment, equal poor effect, the state of an illness increases the weight of year by year, hurt like hell, handicapped, and life can not be taken care of oneself substantially.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, pain obviously alleviates; Continue to take 2 courses for the treatment of, gonalgia transference cure, energy normal activity, recovery from illness.Follow up a case by regular visits to after half a year without recurrence.
Case 2:
Bao, man, 57 years old.Patient's readme: the stair activity gonalgia unbearably, increases the weight of when cold weather or cloudy day, has bone sound during joint motion.Knee joint inspection has bone loose.Be diagnosed as: knee joint hyperosteogeny.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, pain obviously alleviates; Continue to take 2 courses for the treatment of, gonalgia transference cure, energy normal activity, recovery from illness.Follow up a case by regular visits to after half a year without recurrence.
Claims (2)
1. treat the Chinese medicine composition of knee joint hyperosteogeny for one kind, it is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Cibotii 10-30 part, Cortex Eucommiae 5-25 part, Radix Paeoniae Alba 5-20 part, Fructus Psoraleae 10-30 part, Radix Angelicae Sinensis 5-20 part, Cornu Cervi Degelatinatum 10-40 part, Rhizoma Curculiginis 5-20 part, Spina Gleditsiae 10-30 part, Fructus Corni 10-30 part, Rhizoma Coptidis 5-20 part, Fructus Mori 10-30 part, Fructus Ligustri Lucidi 10-30 part, Semen Cuscutae 10-30 part, Herba Scutellariae Barbatae 5-25 part, Pseudobulbus cremastrae seu pleiones 10-30 part, Pericarpium Citri Reticulatae 5-20 part, Herba Hedyotidis Diffusae 10-40 part, Herba Epimedii 5-20 part, Rhizoma Sparganii 5-25 part, Rhizoma Curcumae 5-25 part, Rhizoma Pinelliae 5-20 part, Radix Glycyrrhizae 5-15 part.
2. a kind of Chinese medicine composition for the treatment of knee joint hyperosteogeny according to claim 1, is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Cibotii 20 parts, the Cortex Eucommiae 15 parts, the Radix Paeoniae Alba 10 parts, Fructus Psoraleae 20 parts, Radix Angelicae Sinensis 10 parts, Cornu Cervi Degelatinatum 30 parts, Rhizoma Curculiginis 10 parts, Spina Gleditsiae 20 parts, Fructus Corni 20 parts, Rhizoma Coptidis 10 parts, 20 parts, Fructus Mori, Fructus Ligustri Lucidi 20 parts, Semen Cuscutae 20 parts, Herba Scutellariae Barbatae 15 parts, Pseudobulbus cremastrae seu pleiones 20 parts, Pericarpium Citri Reticulatae 10 parts, Herba Hedyotidis Diffusae 30 parts, Herba Epimedii 10 parts, Rhizoma Sparganii 15 parts, Rhizoma Curcumae 15 parts, the Rhizoma Pinelliae 10 parts, 10 parts, Radix Glycyrrhizae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510016393.XA CN104587393A (en) | 2015-01-14 | 2015-01-14 | Traditional Chinese medicine composition for treating knee-joint hyperostosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510016393.XA CN104587393A (en) | 2015-01-14 | 2015-01-14 | Traditional Chinese medicine composition for treating knee-joint hyperostosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104587393A true CN104587393A (en) | 2015-05-06 |
Family
ID=53113664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510016393.XA Pending CN104587393A (en) | 2015-01-14 | 2015-01-14 | Traditional Chinese medicine composition for treating knee-joint hyperostosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104587393A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007139887A2 (en) * | 2006-05-22 | 2007-12-06 | Cargill, Incorporated | Methods for treating bone or joint inflammation |
CN102188668A (en) * | 2011-03-22 | 2011-09-21 | 张彦 | Chinese medicinal preparation for lumbar vertebra osteoproliferation |
-
2015
- 2015-01-14 CN CN201510016393.XA patent/CN104587393A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007139887A2 (en) * | 2006-05-22 | 2007-12-06 | Cargill, Incorporated | Methods for treating bone or joint inflammation |
CN102188668A (en) * | 2011-03-22 | 2011-09-21 | 张彦 | Chinese medicinal preparation for lumbar vertebra osteoproliferation |
Non-Patent Citations (1)
Title |
---|
谢永玉: "《中医效验方荟萃》", 31 January 2012 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103393840B (en) | A kind of Chinese medicine composition for the treatment of osteoarthritis | |
CN103349753B (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
CN105288230A (en) | Traditional Chinese medicine composition for treating paralysis | |
CN103191383A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
CN103536777B (en) | Traditional Chinese medicinal composition for treating knee osteoarthritis | |
CN103505659A (en) | Chinese proprietary medicine for treating rheumatoid arthritis | |
CN103316141B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
CN104771740A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
CN102793888B (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
CN103028089B (en) | Traditional Chinese medicine composition for treating waist pains of middle-aged and old people | |
CN104888134A (en) | Traditional Chinese medicine composition for treatment of haemorrhoids | |
CN104758720A (en) | Traditional Chinese medicine composition for treating impotence | |
CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
CN104758527A (en) | Traditional Chinese medicine composition for treating pain in waists and legs | |
CN104784417A (en) | Traditional Chinese medicine composition for curing impotentia | |
CN103536856B (en) | A kind of Chinese medicine composition for the treatment of lower abdominal pain | |
CN103272129B (en) | Traditional Chinese medicine composition for treating neurodermatitis | |
CN107551253A (en) | A kind of Chinese medicine preparation and preparation method for treating rheumatic arthritis | |
CN104587393A (en) | Traditional Chinese medicine composition for treating knee-joint hyperostosis | |
CN105560737A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
CN106177775A (en) | A kind of Chinese medicine composition treating hyperosteogeny | |
CN104587394A (en) | Traditional Chinese medicine composition for treating delayed union and nonunion | |
CN104771488A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
CN105663612A (en) | Traditional Chinese medicine composition for treating ankylosing spondylitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150506 |